Discordance in treatment of chronic obstructive pulmonary disease following GesEPOC guideline vs. GOLD.

Chronic obstructive pulmonary disease Enfermedad pulmonar obstructiva crónica Guidelines Normativa Tratamiento Treatment

Journal

Revista clinica espanola
ISSN: 2254-8874
Titre abrégé: Rev Clin Esp (Barc)
Pays: Spain
ID NLM: 101632437

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 14 12 2020
accepted: 27 01 2021
pubmed: 15 9 2021
medline: 15 12 2021
entrez: 14 9 2021
Statut: ppublish

Résumé

Pharmacological treatment of chronic obstructive pulmonary disease in Spain is usually chosen according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) or Spanish guidelines for chronic obstructive pulmonary disease (GesEPOC). The main objective of this study was to evaluate the degree of concordance between treatment for newly diagnosed chronic obstructive pulmonary disease patients according to GOLD and GesEPOC. Simulation study. The following variables were used: FEV The database included 467 patients. Agreement between treatment decided using GOLD and GesEPOC was poor (Kappa: 0.17, 95% CI: 0.12-0.23). There is a poor agreement between GOLD and GesEPOC recommendations for initial chronic obstructive pulmonary disease treatment.

Identifiants

pubmed: 34518150
pii: S2254-8874(21)00128-4
doi: 10.1016/j.rceng.2021.01.009
pii:
doi:

Substances chimiques

Bronchodilator Agents 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

536-539

Informations de copyright

Copyright © 2021 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.

Auteurs

J M Figueira Gonçalves (JM)

Servicio de Neumología y Cirugía Torácica, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain. Electronic address: juanmarcofigueira@gmail.com.

R Golpe (R)

Servicio de Neumología, Hospital Universitario Lucus Augusti, Lugo, Spain; Grupo C039 Biodiscovery HULA-USC, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, A Coruña, Spain.

C Esteban (C)

Servicio de Neumología, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.

M Acosta-Sorensen (M)

Servicio de Neumología y Cirugía Torácica, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.

I Veiga (I)

Servicio de Neumología, Hospital Universitario Lucus Augusti, Lugo, Spain.

I Guzmán-Peralta (I)

Servicio de Neumología, Hospital Universitario Lucus Augusti, Lugo, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH